Mucormycosis (zygomycosis): Is there news for the clinician?
- 31 May 1994
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 28, 1-6
- https://doi.org/10.1016/s0163-4453(94)95896-3
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effectKidney International, 1994
- The Effect of Deferoxamine on Different ZygomycetesThe Journal of Infectious Diseases, 1994
- A Case of Chronic Progressive Rhinocerebral Mucormycosis Treated with Liposomal Amphotericin B and SurgeryClinical Infectious Diseases, 1993
- Cure of Rhizopus Sinusitis in a Liver Transplant Recipient with Liposomal Amphotericin BClinical Infectious Diseases, 1993
- Rhinocerebral mucormycosis following bone marrow transplantationJournal of Infection, 1992
- Treatment with Deferoxamine: A Real Risk Factor for Mucormycosis?Nephron, 1991
- Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis)Kidney International, 1989
- Disseminated Zygomycosis: Report of Four Cases and ReviewClinical Infectious Diseases, 1989
- Adjunctive Hyperbaric Oxygen for Treatment of Rhinocerebral MucormycosisClinical Infectious Diseases, 1988
- Experimental mucormycosis in congenitally athymic (nude) miceMycopathologia, 1977